Strengthening America's Supply Chain of Care
Strengthening the healthcare supply chain in a post-pandemic world
While drug shortages have been a challenge in the U.S. for years, the impact of the pandemic on the entire healthcare supply chain was unprecedented as were resulting effects on patients and care givers.
Fresenius Kabi USA sponsored a Becker's Hospital Review webinar where healthcare leaders discussed how stakeholders can prepare for future disruptions by building more capacity, redundancy and resiliency – and creating the conditions for these necessary capabilities.
- Loressa Cole, DNP, RN, CEO, American Nurses Association
- Valerie Jensen, associate director, CDER drug shortage staff, FDA
- Jonathan Kimball, vice president, trade, international affairs and strategic initiatives, Association for Accessible Medicines
- Scott Meacham, president, pharmaceuticals, Fresenius Kabi USA
Fresenius Kabi expanding its distribution capabilities in the U.S.
Fresenius Kabi has developed an expansive network to deliver more products with more efficiency to customers in need. We’ve invested more than $100 million to create regional-based distribution centers with innovative technologies to deliver the highest quality and care to patients and hospitals across the U.S.
Please watch this video to hear from Senior Vice President Brian Bulgarelli and learn how we’re doing More in America.